Avid Bioservices Inc (CDMO)

[nuke661]

north,
I know this is not directly related to what you were discussing in your post but it does deal with Bavi and its efficacy regarding viruses. When I was recently poking around for information about what Dr. Garnick said about our timeline for Bavi approval process after completion of Sunrise, I saw this question and answer exchange with Steve King that occurred during the 2014 annual shareholders meeting:

Brandon - When we lost the DTRA contract, my understanding is that it was because there was not a single dose that was consistently effective? Is this only true in Ebola?
SK - Part of the problem was that viral moves so fast. Based on our current knowledge of the mechanism of action we can apply it differently now.

I was very intrigued by this statement. We haven't heard squat about viral since the DTRA contract ended and HepC trial data was presented. It would be nice if we could get some more info on what SK meant by this statement.